As a rare but alarming outbreak of infant botulism linked to contaminated baby formula spread across the U.S., Health Writer JoNel Aleccia delivered the ...
UTIs are among the most common bacterial infections worldwide, but inappropriate use and overuse of antibiotics is driving ...
The FDA approves a new subcutaneous formulation of amivantamab, enhancing treatment for advanced lung cancer with reduced administration time and improved safety.
RYBREVANT FASPRO™ is approved across all indications of RYBREVANT® (amivantamab-vmjw)SAN DIEGO, Dec. 18, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc.
We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a ...
More treatments are popping up that promise everything from a quick hangover cure to beauty hacks and energy-giving infusions ...
Milestone Pharmaceuticals Inc.’s CARDAMYST nasal spray wins FDA approval for PSVT, but faces tough competition and market ...
Ophidion, Inc., a biotechnology company pioneering non-invasive delivery of gene-silencing and large-molecule therapeutics to the brain, and Neuronasal, Inc., a clinical-stage company advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback